Die akute Herzinsuffizienz: Rasches Handeln in der
                              Notaufnahme

Mareike Cramer; Ralf Westenfeld; Verena Veulemans

doi:10.1055/a-1486-9126

Notaufnahme up2date, Table of Contents

Notaufnahme up2date 2022; 04(03): 249-265
DOI: 10.1055/a-1486-9126

Thorax, Herz und Atemwege

Die akute Herzinsuffizienz: Rasches Handeln in der Notaufnahme

Mareike Cramer

¹Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf, Dusseldorf, Germany (Ringgold ID: RIN39064)

,

Ralf Westenfeld

¹Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf, Dusseldorf, Germany (Ringgold ID: RIN39064)

,

Verena Veulemans

¹Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf, Dusseldorf, Germany (Ringgold ID: RIN39064)

› Author Affiliations

Abstract

All articles of this category

Die akute Herzinsuffizienz ist eines der häufigsten Krankheitsbilder in der notfallmäßigen Behandlung kardiologischer Erkrankungen. Neben der Symptomkontrolle richtet sich die spezifische Therapie nach den auslösenden Mechanismen, die mannigfaltig sind und dementsprechend erkannt und therapiert werden müssen. Dieser Beitrag gibt einen Einblick in Ursachen, Symptome und Management der akuten Herzinsuffizienz im Bereich einer Chest Pain Unit oder Notaufnahme vor dem Hintergrund der im Herbst 2021 erschienenen neuen Leitlinie der Europäischen Gesellschaft für Kardiologie.

Schlüsselwörter

akute Herzinsuffizienz - Herzunterstützungssysteme - Pharmakotherapie - extrakardiale Ursachen - kardiale Ursachen

Full Text

References

Literatur
1 McDonagh TA, Metra M, Adamo M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42: 3599-3726
2 Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008; 117: 686-697
3 Hochman JS, Sleeper LA, Webb JG. et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 625-634
4 Rogers JG, O’Connor CM. The changing landscape of advanced heart failure therapeutics. J Am Coll Cardiol 2014; 64: 1416-1417
5 Dickstein K, Cohen-Solal A, Filippatos G. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933-989
6 Pan A, Stiell IG, Dionne R. et al. Prehospital use of furosemide for the treatment of heart failure. Emerg Med J 2015; 32: 36-43
7 Chockalingam A, Mehra A, Dorairajan S. et al. Acute left ventricular dysfunction in the critically ill. Chest 2010; 138: 198-207
8 McMurray JJV, Adamopoulos S, Anker SD. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847
9 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der , Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz – Langfassung, 3. Auflage. Version 3. 2019 Accessed April 10, 2022 at: https://www.leitlinien.de/themen/herzinsuffizienz/pdf/herzinsuffizienz-3aufl-vers3.pdf
10 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016; 18: 891-975
11 Farkas JD, Long B, Koyfman A. et al. BRASH Syndrome: Bradycardia, Renal Failure, AV Blockade, Shock, and Hyperkalemia. J Emerg Med 2020; 59: 216-223
12 Paone S, Clarkson L, Sin B. et al. Recognition of Sympathetic Crashing Acute Pulmonary Edema (SCAPE) and use of high-dose nitroglycerin infusion. Am J Emerg Med 2018; 36: 1526.e5-1526.e7
13 Collins S, Martindale J. Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction. Curr Hypertens Rep 2018; 20: 9
14 Beaubien-Souligny W, Rola P, Haycock K. et al. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J 2020; 12: 16
15 Felker GM, Benza RL, Chandler AB. et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003; 41: 997-1003
16 MebazaAaNieminen MS, Packer M. et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007; 297: 1883-1891
17 Alkhouli M, Osman M, Elsisy MFA. et al. Mechanical Circulatory Support in Patients with Cardiogenic Shock. Curr Treat Options Cardiovasc Med 2020; 22: 4
18 Combes A, Price S, Slutsky AS. et al. Temporary circulatory support for cardiogenic shock. Lancet 2020; 396: 199-212
19 Thiele H, Zeymer U, Neumann FJ. et al. Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators, Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638-1645
20 O’Neill WW, Schreiber T, Wohns DHW. et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 2014; 27: 1-11
21 Lauten A, Engström AE, Jung C. et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circulation Heart Fail 2013; 6: 23-30
22 Werdan K, Gielen S, Ebelt H. et al. Mechanical circulatory support in cardiogenic shock. Eur Heart J 2014; 35: 156-167
23 Trummer G, Benk C, Beyersdorf F. Controlled automated reperfusion of the whole body after cardiac arrest. J Thorac Dis 2019; 11: S1464-S1470
24 Kar B, Basra SS, Shah NR. et al. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation 2012; 125: 1809-1817